Meyka Pro banner
Nyxoah S.A.

Nyxoah S.A. (NYXH) Stock Overview

Explore Nyxoah S.A.’s financial performance, market position, analyst ratings, and future outlook.

NYXHNASDAQ
HealthcareMedical - Specialties
$1.54
$0.02(1.28%)
U.S. Market opens in 11h 24m

Nyxoah S.A. (NYXH)

Meyka AI Score

Z

Key Financials

Market Cap61M
P/E Ratio-0.63
EPS (TTM)$-2.48
ROE-1.64%
Fundamental Analysis

AI Price Forecasts

1 Month$0.88
3 Months$0.68
1 Year Target$0.00

NYXH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nyxoah S.A. (NYXH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.40, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.63 and a market capitalization of 61M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.28%
5-Day Change
-3.14%
1-Month Change
-1.91%
3-Month Change
-52.17%
6-Month Change
-67.58%
Year-to-Date (YTD) Change
-66.52%
1-Year Change
-80.60%
3-Year Change
-80.10%
5-Year Change
-95.36%
All-Time (Max) Change
-93.58%

Contact Information

32 1 022 23 55
Rue Edouard Belin 12, Mont-Saint-Guibert, WA, 1435

Company Facts

1,630 Employees
IPO DateApr 28, 2021
CountryBE
Actively Trading

Frequently Asked Questions